Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTOR | AZN | AMGN | GILD | VRTX |
| Company | Citius Oncology Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0000 | 196.72 | 376.17 | 147.78 | 486.13 |
| High | 1.0000 | 197.01 | 376.97 | 148.26 | 499.00 |
| Low | 0.9800 | 196.58 | 374.41 | 147.78 | 480.63 |
| Latest | 1.0000 | 196.47 | 373.81 | 147.92 | 505.74 |
| Change | -0.0100 | +1.52 | -3.16 | +1.29 | +44.87 |
| % Change | -0.99% | +0.78% | -0.84% | +0.88% | +9.74% |
| Volume | 170,275 | 25,069 | 66,940 | 15,403 | 58,735 |
| 20-Day Average Volume | 386,694 | 2,127,749 | 2,552,067 | 7,102,235 | 1,367,922 |
| Previous Close | 1.0100 | 194.95 | 376.97 | 146.63 | 460.87 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1138 | 202.97 | 375.77 | 149.38 | 475.89 |
| 20-Day Raw Stochastic | 9.37% | 31.53% | 46.78% | 36.60% | 88.60% |
| 20-Day Relative Strength | 39.88 | 50.66 | 55.98 | 56.11 | 58.03 |
| Weighted Alpha | -20.94 | +32.76 | +28.11 | +40.33 | +8.03 |
| Today's Opinion | 88% Sell | 80% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 80% Buy | 100% Buy | 88% Buy | 64% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.96% since 03/03/26 | -2.50% since 03/03/26 | -0.49% since 03/03/26 | +0.17% since 03/03/26 | +4.96% since 03/03/26 |
| Low | 0.9696 on 03/09/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 1.1000 on 03/04/26 | 203.29 on 03/04/26 | 380.09 on 03/04/26 | 148.92 on 03/04/26 | 499.00 on 03/10/26 |
| 1-Month | |||||
| %Chg | -11.79% since 02/10/26 | +1.71% since 02/10/26 | +2.88% since 02/10/26 | +0.58% since 02/10/26 | +7.41% since 02/10/26 |
| Low | 0.9696 on 03/09/26 | 189.35 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 1.2600 on 02/12/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 3-Month | |||||
| %Chg | -11.79% since 12/10/25 | +7.48% since 12/10/25 | +18.96% since 12/10/25 | +22.04% since 12/10/25 | +11.96% since 12/10/25 |
| Low | 0.9500 on 12/31/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 1.4400 on 12/19/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 6-Month | |||||
| %Chg | -46.70% since 09/10/25 | +21.71% since 09/10/25 | +34.71% since 09/10/25 | +28.49% since 09/10/25 | +28.12% since 09/10/25 |
| Low | 0.9384 on 12/09/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 2.2500 on 10/16/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 89,158 | 302,349,504 | 203,212,464 | 182,029,584 | 117,076,648 |
| Shares Outstanding, K | 88,275 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -24,760,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 3,940,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -5,530,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 3.02 | 0.32 | 0.45 | 0.36 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 12/23/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 02/13/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.20 | 16.91 | 17.66 | 27.81 |